in | |||||
WEB | |||||
EMA evaluating the use of COVID-19 Vaccine Moderna in young people aged 12 to 17 | European ... It is currently authorised for use in people aged 18 and older. It contains a molecule called messenger RNA (mRNA) with instructions for producing a ...
| |||||
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
No comments:
Post a Comment